Supplemental Tables S1-S4; Checkpoint Inhibitor Antibody Type Influences the Development of Cutaneous Immune-Related Adverse Events: A Multi-institutional Study
Published: 13 September 2023| Version 1 | DOI: 10.17632/grsvxxnkvk.1
Contributor:
Kathleen RosterDescription
Supplemental Tables S1-S4
Files
Categories
Antibody, Immune Checkpoint Inhibitor